C12N 2710/00
Dsdna viruses
Official title: dsDNA viruses
C12N2710/00 (Dsdna viruses) appears on 6,981 US grants and 9,753 published applications in this corpus.
Search patents in C12N- Granted patents
- 6,981
- Published applications
- 9,753
- Assignees
- 3,173
- Inventors
- 14,901
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 9 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 5 | 0 |
| 1981 | 5 | 0 |
| 1982 | 6 | 0 |
| 1983 | 9 | 0 |
| 1984 | 5 | 0 |
| 1985 | 8 | 0 |
| 1986 | 15 | 0 |
| 1987 | 17 | 0 |
| 1988 | 18 | 0 |
| 1989 | 19 | 0 |
| 1990 | 16 | 0 |
| 1991 | 36 | 0 |
| 1992 | 50 | 0 |
| 1993 | 64 | 0 |
| 1994 | 57 | 0 |
| 1995 | 57 | 0 |
| 1996 | 68 | 0 |
| 1997 | 159 | 0 |
| 1998 | 258 | 0 |
| 1999 | 214 | 0 |
| 2000 | 225 | 0 |
| 2001 | 244 | 70 |
| 2002 | 210 | 319 |
| 2003 | 201 | 419 |
| 2004 | 183 | 393 |
| 2005 | 138 | 373 |
| 2006 | 179 | 339 |
| 2007 | 167 | 317 |
| 2008 | 156 | 303 |
| 2009 | 162 | 350 |
| 2010 | 188 | 357 |
| 2011 | 182 | 342 |
| 2012 | 164 | 305 |
| 2013 | 170 | 287 |
| 2014 | 212 | 311 |
| 2015 | 216 | 351 |
| 2016 | 212 | 360 |
| 2017 | 264 | 372 |
| 2018 | 279 | 415 |
| 2019 | 299 | 455 |
| 2020 | 300 | 500 |
| 2021 | 270 | 500 |
| 2022 | 288 | 554 |
| 2023 | 261 | 532 |
| 2024 | 252 | 494 |
| 2025 | 286 | 453 |
| 2026 | 164 | 282 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis6 Oct 2026US 12,753,384 B2Cornell Research Foundation, Inc.
- Recombinant modified vaccinia virus (MVA) vaccine against coronavirus disease29 Sep 2026US 12,746,282 B2Bavarian Nordic A/S
- Method for production of Varicella Zoster Virus surface protein antigen29 Sep 2026US 12,747,427 B2The Green Cross Corporation
- Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency29 Sep 2026US 12,747,429 B2The Trustees of the University of Pennsylvania
- Engineered DNA molecule for coding RNA22 Sep 2026US 12,742,172 B2Rinuagene Biotechnology Co., Ltd.
- Vaccines against african swine fever virus, and methods of using same8 Oct 2026US 2026/0306608 A1The Wistar Institute of Anatomy and Biology
- Treating a type i interferon upregulation or aberrant il-33 upregulation disease or condition with polyomavirus8 Oct 2026US 2026/0306609 A1The General Hospital Corporation
- Tumor neoantigen vaccine system specifically marking heterologous protein, and use thereof8 Oct 2026US 2026/0306620 A1China Pharmaceutical University
- A novel non-stoichiometric multi-element adjuvant (nsma) and composition thereof8 Oct 2026US 2026/0306624 A1Magvitae Innovations Inc
- Adenovirus vector circular rna expression system8 Oct 2026US 2026/0306666 A1
Most cited
By later US patents
- Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site1,449US 7,718,180 B22010
- Plant expression constructs1,417US 6,660,911 B2Monsanto Technology LLC · 2003
- Chimeric figwort mosaic virus-elongation factor 1 α promoters and methods of using them1,389US 6,949,696 B2Monsanto Technology LLC · 2005
- Glyphosate resistant plants using hybrid promoter constructs1,380US 7,141,722 B2Monsanto Technology LLC · 2006
- Methods of treating HIV infected subjects386US 6,905,680 B2Genetics Institute, Inc. · 2005